載入...
Captopril: 4 years of post marketing surveillance of all patients in New Zealand.
The Intensive Medicines Monitoring Programme (IMP), a specialised part of the New Zealand Post Marketing Surveillance system, has been used to monitor captopril since it was first approved for marketing for the treatment of hypertension and heart failure. Monitoring has consisted of (1) spontaneous...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
1987
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1386188/ https://ncbi.nlm.nih.gov/pubmed/3297125 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|